Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Blood
|
June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1
Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Nature
|
October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancer
Daichi Inoue, Guo-Liang Chew, Bo Liu, et al.
Nature Cancer
|
October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Katherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Journal of Biochemistry
|
November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)
Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.
Nature Communications
|
December 15, 2023
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state
Muran Xiao, Shinji Kondo, Masaki Nomura, et al.
Cancer Cell
|
August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
Stanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
The Journal of Clinical Investigation
|
June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
Justin Taylor, Dean Pavlick, Akihide Yoshimi, et al.
Blood
|
June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
Atsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Blood Cancer Journal
|
September 22, 2021
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
Nora E Rahmani, Nandini Ramachandra, Srabani Sahu, et al.
Cancer Discovery
|
July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Blood
|
June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1
Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Nature
|
October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancer
Daichi Inoue, Guo-Liang Chew, Bo Liu, et al.
Nature Cancer
|
October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Katherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Journal of Biochemistry
|
November 22, 2015
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD)
Toshio Kitamura, Naoko Watanabe-Okochi, Yutaka Enomoto, et al.
Nature Communications
|
December 15, 2023
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state
Muran Xiao, Shinji Kondo, Masaki Nomura, et al.
Cancer Cell
|
August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
Stanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
The Journal of Clinical Investigation
|
June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
Justin Taylor, Dean Pavlick, Akihide Yoshimi, et al.
Blood
|
June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
Atsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Blood Cancer Journal
|
September 22, 2021
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
Nora E Rahmani, Nandini Ramachandra, Srabani Sahu, et al.
Cancer Discovery
|
July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Page
of 9